Jason M Schenkel

10PUBLICATIONS
77CO-AUTHORS
AutoimmunityInnate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 05, 2026
IGF1 modulates lesional skin inflammation in checkpoint inhibitor-induced lichen planus.

|Feb 12, 2026
Lymph node resident memory T cells retain effector capabilities by evading lung resident memory dysfunction.

Taylor A Heim, Zachary J Rogers, Sarah Duquette

|Jul 24, 2025
PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashion.

Kristen E Pauken, Samuel C Markson, Thomas S Conway

|Mar 05, 2025
Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma.

Kelly M Mahuron, Osmaan Shahid, Prachi Sao

|Aug 16, 2024
<i>In vivo</i> antibody labeling route and fluorophore dictate labeling efficiency, sensitivity, and longevity.

Natalie B Hagan, Charles Inaku, Nikesh Kunder

|May 30, 2023
Localization, tissue biology and T cell state - implications for cancer immunotherapy.

Jason M Schenkel, Kristen E Pauken

Pageof 2

Frequent Collaborators

5 joint publications

Kristen E Pauken

3 joint publications

Arlene H Sharpe

2 joint publications

Meromit Singer

2 joint publications

Osmaan Shahid